drugset / Trial / NCT00462644

Evaluation of Etomidate on Adrenal Function in Trauma Patients

NCT00462644

Completed 30 enrolled University of Tennessee
RandomizedParallel-groupOpen-labelPrevention

Summary

Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients.

Timeline

Start
2006-02
Primary completion
2006-08
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etomidate Small molecule 0.3 mg/kg Intravenous
Comparator Fentanyl Other / unclassified 100 ug Intravenous
Comparator Midazolam Small molecule 5 mg Intravenous
Comparator Suxamethonium Other / unclassified 1 mg/kg Intravenous